19,248 CVS Health Corporation $CVS Shares Sold by Nisa Investment Advisors LLC

Key Points

• Nisa Investment Advisors reduced its CVS Health stake by 5.6%, selling 19,248 shares and retaining 324,307 shares valued at approximately $27.79 million. Institutional investors collectively own 80.66% of CVS shares.
• Analysts remain broadly positive, with 20 Buy ratings and three Hold ratings, producing a consensus rating of Moderate Buy and an average price target of $107.80.
• CVS reported quarterly EPS of $2.58, surpassing the $1.87 estimate, while revenue rose 7.3% year over year to $106.1 billion. The company maintained a quarterly dividend of $0.665 per share, equivalent to a 2.8% yield.

Nisa Investment Advisors LLC lowered its stake in CVS Health Corporation (NYSE:CVS - Free Report) by 5.6% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 324,307 shares of the pharmacy operator's stock after selling 19,248 shares during the period. Nisa Investment Advisors LLC's holdings in CVS Health were worth $27,790,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the stock. Kilter Group LLC bought a new stake in shares of CVS Health during the second quarter worth approximately $27,000. Beaird Harris Wealth Management LLC increased its stake in shares of CVS Health by 201.0% during the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator's stock worth $30,000 after purchasing an additional 195 shares during the period. J.Safra Asset Management Corp acquired a new stake in CVS Health during the 2nd quarter worth approximately $30,000. Timbuktu Capital Management LLC bought a new stake in CVS Health in the 2nd quarter valued at $31,000. Finally, Dunhill Financial LLC bought a new stake in CVS Health in the 2nd quarter valued at $32,000. 80.66% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of research reports. Truist Financial upped their price objective on CVS Health from $108.00 to $118.00 and gave the company a "buy" rating in a report on Tuesday, July 14th. Argus lifted their target price on CVS Health from $104.00 to $114.00 and gave the stock a "buy" rating in a report on Wednesday, August 19th. UBS Group reissued a "buy" rating on shares of CVS Health in a research report on Tuesday, September 22nd. Robert W. Baird set a $107.00 target price on shares of CVS Health in a research report on Thursday, August 6th. Finally, Cantor Fitzgerald restated a "neutral" rating on shares of CVS Health in a research note on Friday, October 9th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $107.80.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Opportunity to gain pharmacy customers: CVS is targeting customers displaced by Walgreens and Rite Aid store closures. The initiative could support prescription volume, retail sales and customer retention if CVS successfully converts those patients. CVS targets former Walgreens, Rite Aid customers after 1,000 stores close
• Positive Sentiment: Aetna administrative improvements: CVS says Aetna is streamlining prior authorizations, approving more than 95% of eligible requests within 24 hours and expanding bundled approvals. Faster decisions could improve member and provider satisfaction while reducing administrative costs. How CVS’ Aetna Is Advancing Efforts to Reduce Administrative Burden
• Positive Sentiment: MinuteClinic expansion: Three new Massachusetts locations—including the first in Boston—expand CVS’s healthcare footprint and may increase patient traffic, service revenue and cross-selling opportunities. MinuteClinic opens three new retail medical clinics
• Neutral Sentiment: Leadership transition: Chief Information Officer Amaresh Siva is leaving CVS to become Alaska Airlines’ chief information technology officer. The departure may create near-term technology and AI execution uncertainty, though it does not directly change CVS’s financial outlook. Alaska Airlines taps CVS Health executive for new technology role
• Negative Sentiment: Industry and valuation concerns: Coverage highlights pressure from rising medical costs across managed care, uncertainty surrounding Medicare Advantage plan availability and technical weakness after CVS raised its outlook. These issues could limit valuation expansion despite the company’s improved earnings guidance. Management raised the bar for CVS Health stock

CVS Health Stock Up 2.3%

NYSE CVS opened at $94.77 on Wednesday. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 1-year low of $69.51 and a 1-year high of $110.68. The company has a 50 day moving average of $91.70 and a 200-day moving average of $93.49. The company has a market cap of $121.21 billion, a price-to-earnings ratio of 11.82, a PEG ratio of 0.86 and a beta of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. The business had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same quarter in the prior year, the business posted $1.81 earnings per share. The firm's quarterly revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, equities research analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd will be issued a dividend of $0.6650 per share. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. The ex-dividend date of this dividend is Thursday, October 22nd. CVS Health's dividend payout ratio is 70.37%.

CVS Health Company Profile

CVS Health Corporation NYSE: CVS is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company's Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.